Business
Press Release Nov 08 2022
Lupin Limited has informed the Exchange about press release dated 08-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules.
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange about press release dated 08-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules. View Attachment","length":321,"tagName":"div"}]